JPS5899472A - 25-hydroxyvitamin d3 26,33-lactol - Google Patents

25-hydroxyvitamin d3 26,33-lactol

Info

Publication number
JPS5899472A
JPS5899472A JP19625381A JP19625381A JPS5899472A JP S5899472 A JPS5899472 A JP S5899472A JP 19625381 A JP19625381 A JP 19625381A JP 19625381 A JP19625381 A JP 19625381A JP S5899472 A JPS5899472 A JP S5899472A
Authority
JP
Japan
Prior art keywords
hydroxyvitamin
lactol
formula
aluminum hydride
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP19625381A
Other languages
Japanese (ja)
Other versions
JPH0261469B2 (en
Inventor
Hiroaki Takayama
浩明 高山
Sachiko Yamada
幸子 山田
Keiko Nakayama
中山 恵子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP19625381A priority Critical patent/JPS5899472A/en
Publication of JPS5899472A publication Critical patent/JPS5899472A/en
Publication of JPH0261469B2 publication Critical patent/JPH0261469B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:The 25-hydroxyvitamin D3 26,23-lactol of formula. USE:A drug having vitamin D3-mimic bioactivity. PROCESS:The compound of formula can be prepared by reducing 25-hydroxyvitamin D3 26,23-lactone with a metal hydride (e.g. lithium aluminum hydride, diisobutyl aluminum hydride, etc.) in an inert solvent such as toluene.

Description

【発明の詳細な説明】 本発明は式(1)で示される25−ヒドロキシビタミン
D326.23−ラクトールに関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to 25-hydroxyvitamin D326.23-lactol represented by formula (1).

式(1)で示されるビタミンD3誘導体は新規化合物で
あり、例えば他用等の方法(Ohem、 PharzB
ull、e2g(9)、2852(1980))によっ
て得られる25−ヒドロキシビタミンD326.23−
ラクトンをトルエン等の不活性溶媒中水素化金属類例え
ばリチウム水素化アルミニウム、ジイソブチル水素化ア
ルミニウム(DIBAL)等を用いて還元するととKよ
り得られる。
The vitamin D3 derivative represented by formula (1) is a new compound, and can be used, for example, by methods such as those used by others (Ohem, PharzB
25-hydroxyvitamin D326.23- obtained by Ull, e2g (9), 2852 (1980))
K is obtained by reducing the lactone with a metal hydride such as lithium aluminum hydride, diisobutyl aluminum hydride (DIBAL), etc. in an inert solvent such as toluene.

このようにして得られる本発明の化合物(1)はビタミ
ンD様の生物活性を有し医薬として有用である。
The compound (1) of the present invention thus obtained has vitamin D-like biological activity and is useful as a medicine.

実施例。Example.

(1”)             (Tり化合物(i
t)1.8Mgをトルエン300μIK溶解し一70℃
にてジイソブチル水素化アルミニウム((DIBAL)
の25%ヘキサン溶液26.5μj!を加え一70℃で
2時間攪拌する。エタノール150μLを加え過剰のD
IBALを分解後室温に戻しクロロホルムで希釈し5%
塩酸水で洗浄、億酸す) IJウムで乾燥し溶媒を留去
すふ、残渣をセファデックxT、H−20Cffl媒ク
ロロホルム、ヘキサン、メタノール、65:35:2)
を用いたカラムクロマトグラフィーに付し精製しく23
8.2SR)−25−ヒドロキシビタきンD326.2
3−ラクトール(1’) 1.67119を得る。
(1”) (T compound (i
t) Dissolve 1.8Mg in toluene 300μIK and heat to -70℃
Diisobutyl aluminum hydride ((DIBAL)
26.5μj of 25% hexane solution! and stirred at -70°C for 2 hours. Add 150 μL of ethanol and remove excess D.
After decomposing IBAL, return to room temperature and dilute with chloroform to 5%
Wash with hydrochloric acid water, dilute with 100,000 ml of acid), dry with IJum, distill off the solvent, and dissolve the residue in Sephadec xT, H-20Cffl (chloroform, hexane, methanol, 65:35:2).
It was purified by column chromatography using 23
8.2SR)-25-Hydroxyvitanquin D326.2
3-lactol (1') 1.67119 is obtained.

−vX2ベクトル”/:430(M”)#41L394
1379.356,342,136,118’HNMR
Xベクトル(0DOj!3) J : 0.55 (3
H,s)。
-vX2 vector”/:430(M”) #41L394
1379.356,342,136,118'HNMR
X vector (0DOj!3) J: 0.55 (3
H,s).

1.34(38,s) 、3.8〜4.2(2H,惰)
、4.83(2H,bs) 、5.07(IH,ba)
 、6.14(2H,ABq。
1.34 (38, s), 3.8~4.2 (2H, inertia)
, 4.83 (2H, bs), 5.07 (IH, ba)
, 6.14 (2H, ABq.

J−11H1) UVスペクトル:λ−(局方エタノール)265%S。J-11H1) UV spectrum: λ- (pharmacopoeial ethanol) 265% S.

1m1%228ss 出願人  中外製薬株式会社1m1%228ss Applicant: Chugai Pharmaceutical Co., Ltd.

Claims (1)

【特許請求の範囲】 式 で示されるビタミンD3誘導体。[Claims] formula A vitamin D3 derivative represented by
JP19625381A 1981-12-08 1981-12-08 25-hydroxyvitamin d3 26,33-lactol Granted JPS5899472A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19625381A JPS5899472A (en) 1981-12-08 1981-12-08 25-hydroxyvitamin d3 26,33-lactol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19625381A JPS5899472A (en) 1981-12-08 1981-12-08 25-hydroxyvitamin d3 26,33-lactol

Publications (2)

Publication Number Publication Date
JPS5899472A true JPS5899472A (en) 1983-06-13
JPH0261469B2 JPH0261469B2 (en) 1990-12-20

Family

ID=16354728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19625381A Granted JPS5899472A (en) 1981-12-08 1981-12-08 25-hydroxyvitamin d3 26,33-lactol

Country Status (1)

Country Link
JP (1) JPS5899472A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04118164U (en) * 1991-03-29 1992-10-22 タキロン株式会社 fountain device

Also Published As

Publication number Publication date
JPH0261469B2 (en) 1990-12-20

Similar Documents

Publication Publication Date Title
JPH01213270A (en) Novel 3, 5-dihydroxycarboxylic acid and its derivative
KR840000678B1 (en) Method of preparing for sugar derivatives
JPS5899472A (en) 25-hydroxyvitamin d3 26,33-lactol
JPS60109541A (en) Diarylindan-1,3-dione, preparation and use
JP3108474B2 (en) Active vitamin D derivative
JPS61197573A (en) 5,6-epoxidized trans-vitamin d3
JPH06256334A (en) Production of cis-whiskey lactone
JPH0357915B2 (en)
JP2631668B2 (en) New urocanic acid derivatives
JPH04244076A (en) Vitamin a acid ester compound
JPS62187431A (en) Mono-, di- and tri-ester of 1,8-dihydroxy-10-phenyl-9-anthrone or 9-anthranol, manufacture and medicinal and cosmetic composition
JPS6377868A (en) Alpha-(omega-hydroxyalkyl)furfuryl alcohol and production thereof
JPH0523264B2 (en)
JPH01153655A (en) 2-n-octyl-3-hydroxy-n-dodecanoic acid and ester thereof
JPS63183579A (en) Novel 2h-1-benzopyran derivative
JPH04244058A (en) Vitamin a acid ester compound
Liu et al. Selective reduction of N-protected-α-amino lactones to lactols with lithium tri-tert-butoxyaluminohydride
DE2807588A1 (en) Antiviral 2'-deoxy-ribofuranoside nucleoside derivs. - prepd. by esterifying 2'-deoxy-uridine derivs. with 1-adamantane-carboxylic acid
JPH01193288A (en) Unsaturated alycyclic ester of macrolide and lincosamide antibiotics, production thereof and drug/cosmetics
JPH01106842A (en) 2-n-decyl-3-hydroxy-n-tetradecanoic acid and ester thereof
JPH0215065A (en) Production of high-purity o-5,6,7,8-tetrahydronaphthyl-n-methyl-n-(6-methoxy-2-pyridyl)thiocarbamate
JPH0645572B2 (en) Process for producing 2-hydroxy-3-butenoic acid derivative
JPS6126555B2 (en)
JPH03167180A (en) Production of 4-substituted gamma-lactone compounds
JPS6251964A (en) Perfumery composition containing terpene-gamma-lactone compound